Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mónica Ribell-Bachs"'
Autor:
Gerardo Rojo-Marcos, José Miguel Rubio-Muñoz, Germán Ramírez-Olivencia, Silvia García-Bujalance, Rosa Elcuaz-Romano, Marta Díaz-Menéndez, María Calderón, Isabel García-Bermejo, José Manuel Ruiz-Giardín, Francisco Jesús Merino-Fernández, Diego Torrús-Tendero, Alberto Delgado-Iribarren, Mónica Ribell-Bachs, Juan Arévalo-Serrano, Juan Cuadros-González
Publikováno v:
Emerging Infectious Diseases, Vol 20, Iss 3, Pp 417-424 (2014)
Sequencing data from Plasmodium ovale genotypes co-circulating in multiple countries support the hypothesis that P. ovale curtisi and P. ovale wallikeri are 2 separate species. We conducted a multicenter, retrospective, comparative study in Spain of
Externí odkaz:
https://doaj.org/article/833665cacdd54579a8198e15967cf52f
Autor:
Marta Díaz-Menéndez, Francisco Jesús Merino-Fernández, Germán Ramírez-Olivencia, Silvia García-Bujalance, José Miguel Rubio-Muñoz, Juan Cuadros-González, José Manuel Ruiz-Giardín, Mónica Ribell-Bachs, Diego Torrús-Tendero, Rosa Elcuaz-Romano, Gerardo Rojo-Marcos, Juan Arévalo-Serrano, María Calderón, Alberto Delgado-Iribarren, Isabel García-Bermejo
Publikováno v:
Emerging Infectious Diseases, Vol 20, Iss 3, Pp 417-424 (2014)
Repisalud
Instituto de Salud Carlos III (ISCIII)
Emerging Infectious Diseases
Repisalud
Instituto de Salud Carlos III (ISCIII)
Emerging Infectious Diseases
Sequencing data from Plasmodium ovale genotypes co-circulating in multiple countries support the hypothesis that P. ovale curtisi and P. ovale wallikeri are 2 separate species. We conducted a multicenter, retrospective, comparative study in Spain of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b3c71634d32c8f7946a30820d2a129a2
https://doi.org/10.3201/eid2003.130745
https://doi.org/10.3201/eid2003.130745
Autor:
Enric Pedrol-Clotet, Immaculada Vidal-Castell, Anna Soler, Mónica Ribell-Bachs, Pedro García-Rodríguez, Elisabet Deig-Comerma
Publikováno v:
Enfermedades Infecciosas y Microbiología Clínica. 24:509-511
Smoking is the most important modifiable cardiovascular risk factor. Bupropion administration is an effective method to achieve smoking cessation (SC), but the drug is metabolized by the cytochrome P450 enzyme system and this might cause interactions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12e95a140757d33c1c862d015993f122
https://doi.org/10.1157/13092468
https://doi.org/10.1157/13092468
Autor:
Enric, Pedrol-Clotet, Elisabet, Deig-Comerma, Mónica, Ribell-Bachs, Immaculada, Vidal-Castell, Pedro, García-Rodríguez, Anna, Soler
Publikováno v:
Enfermedades infecciosas y microbiologia clinica. 24(8)
Smoking is the most important modifiable cardiovascular risk factor. Bupropion administration is an effective method to achieve smoking cessation (SC), but the drug is metabolized by the cytochrome P450 enzyme system and this might cause interactions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::9a5900d763dcd8fc6e5cf87651dcaf3b
https://pubmed.ncbi.nlm.nih.gov/16987469
https://pubmed.ncbi.nlm.nih.gov/16987469